Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

CompletedOBSERVATIONAL
Enrollment

466

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

July 25, 2024

Study Completion Date

July 25, 2024

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentMild Dementia
Trial Locations (7)

23507

East Virginia Medical School (EVMS), Norfolk

33175

Ezy Medical Research, Miami

89106

Lou Ruvo Center for Brain Health at Cleveland Clinic (LR-CC), Las Vegas

98104

University of Washington (MBWC), Seattle

K1Z 1G3

Ottawa Memory Clinic (OMC), Ottawa

M4G 3E8

Centricity Research, Toronto

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

Sponsors
All Listed Sponsors
collaborator

Eastern Virginia Medical School

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University of Washington

OTHER

collaborator

Sunnybrook Research Institute

OTHER

lead

Optina Diagnostics Inc.

INDUSTRY

NCT05107882 - Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test | Biotech Hunter | Biotech Hunter